This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

LSX Investival Showcase London
Monday 16 November 2026
Old BillingsgateLondon, UK

Michel de Baar
Venture Partner at Thuja Capital
Speaker

Profile

Michel is a life sciences investor and seasoned business development and licensing professional with experience in all elements of the business development processes. He holds a PhD from the University of Amsterdam and an MBA from Rotterdam School of Management. In 2016, Michel joined the Global Business Development & Licensing (BD&L) team of MSD to help augment the pipeline after having had various BD&L roles at various biotech companies and research institutes. Since July this year, he’s joined Thuja Capital as Venture Parter to help create deal flow, and to help evaluate the many investment opportunities the Thuja receives each year.

Agenda Sessions

  • Why a Robust Clinical Strategy is Your Key to Growth-Stage Investment

    , 16:30